Bioenergetic Metabolism Modulatory Peptide Hydrogel for Cardiac Protection and Repair After Myocardial Infarction
- 12 January 2024
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (24)
Abstract
Myocardial infarction (MI) remains a major threat to human health due to the limited energy supply, disordered cell metabolism, massive cardiomyocyte death, and restricted regeneration. Although currently available therapies may relieve myocardial damage, restoring the dysregulated energy metabolism to normal levels has not yet been achieved. MOTS‐c has recently been identified as a regulator of biological metabolism to combat aging; however, its role in reprogramming cardiac metabolism remains to be elucidated. Here, MOTS‐c is chemically conjugated to self‐assembling Q11 peptide to fabricate an injectable hydrogel (MQgel) aimed to improve mitochondria function and cardiomyocyte metabolism post‐MI. It is observed that MQgel effectively protects mitochondria from oxidative damage and normalized cardiomyocyte metabolism, including glucose uptake, glycolysis, and the tricarboxylic acid (TCA) cycle, thereby inhibiting cardiomyocyte death and enhancing cardiomyocyte activity. In a rat MI model, intramyocardial injection of MQgel successfully minimizes the infarct area and fibrosis, promotes angiogenesis, suppresses myocardial hypertrophy, and improves cardiomyocyte survival and metabolic enzyme activity, all of which collaboratively attenuate the maladaptive cardiac remodeling and boost cardiac function and tissue repair. The findings suggest that the self‐assembled mitochondria metabolism‐regulatory peptide hydrogel effectively treats MI, and cellular bioenergy modulation provides a new therapeutic approach for tissue repair after injury.Keywords
Funding Information
- Natural Science Foundation of Tianjin Municipality (22JCQNJC00120)
- Fundamental Research Funds for the Central Universities (2019PT350005)
- National Natural Science Foundation of China (8227162)
This publication has 50 references indexed in Scilit:
- MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolismFree Radical Biology and Medicine, 2016
- An injectable silk sericin hydrogel promotes cardiac functional recovery after ischemic myocardial infarctionActa Biomaterialia, 2016
- Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart FailureCirculation: Heart Failure, 2016
- A Unifying Mechanism for Mitochondrial Superoxide Production during Ischemia-Reperfusion InjuryCell Metabolism, 2016
- Succinate dehydrogenase inhibition with malonate during reperfusion reduces infarct size by preventing mitochondrial permeability transitionCardiovascular Research, 2015
- Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarctionBiomaterials, 2015
- The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin ResistanceCell Metabolism, 2015
- Metabolomic Analysis of Pressure-Overloaded and Infarcted Mouse HeartsCirculation: Heart Failure, 2014
- Left Ventricular Remodeling in Heart FailureJACC: Cardiovascular Imaging, 2011
- Effect of Injectable Alginate Implant on Cardiac Remodeling and Function After Recent and Old Infarcts in RatCirculation, 2008